Apolipoprotein B/A Ratio
Ordering Recommendation
Acceptable nontraditional secondary cardiovascular risk screen for specific populations.
New York DOH Approval Status
Specimen Required
Fasting specimen recommended.
Serum separator tube, plasma separator tube, K2EDTA, lithium heparin
Allow specimen to clot completely at room temperature. Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP standard transport tube. (Min: 0.5 mL)
Refrigerated.
After separation from cells: Ambient: 24 hours; Refrigerated: 8 days; Frozen: 2 months
Methodology
Quantitative Immunoturbidimetry
Performed
Sun-Sat
Reported
Within 24 hours
Reference Interval
Test Number |
Components |
Reference Interval |
||||
---|---|---|---|---|---|---|
Apolipoprotein B |
|
|||||
Apolipoprotein A-1 |
|
Interpretive Data
The ratio of apolipoprotein B/A can provide an estimate of the risk for major adverse cardiovascular events in adults.
Apolipoprotein B/A Ratio: | |
---|---|
Low Risk | 0.2 - 0.6 |
Medium Risk | 0.61 - 0.90 |
High Risk | 0.91 - 5.0 |
FDA
Note
Hotline History
Hotline History
CPT Codes
82172 x2
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0050027 | Apolipoprotein B/A Ratio | 1874-7 |
0050029 | Apolipoprotein B | 1871-3 |
0050030 | Apolipoprotein A-1 | 1869-7 |
Aliases
- Apo B & A ratio
- Apolipoprotein A-1 & B
- Apolipoprotein A1 and B, Plasma
- Apolipoprotein A1 and B-100, Plasma
- Apolipoprotein APO A/B Ratio